Novartis AG vs United Airlines Holdings Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while United Airlines Holdings Inc trades at $118.05 (market cap $38.15B). The key difference: Novartis AG is far larger — about 7.6× United Airlines Holdings Inc's market cap, and Novartis AG pays a 3.17% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals.
| NVS | UAL | |
|---|---|---|
Market Cap | $290.25B | $38.15B |
Sector | Health | Industrials |
52-Week High | $168.62 | $136.11 |
52-Week Low | $113.50 | $84.57 |
Enterprise Value | $330.27B | $55.18B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →